Learn how Series 86 tests debt, leverage, interest coverage, liquidity, M&A, restructuring, divestitures, return metrics, share count, and governance evidence.
Series 86 expects the analyst to understand how financing choices, corporate actions, and governance affect the research view. Two companies with similar operating results may deserve different conclusions if one has heavy refinancing risk, weak liquidity, dilutive issuance, acquisition integration risk, or governance concerns that reduce confidence in management’s plan.
This section sits at the end of Function 2 because it turns company analysis into a risk-adjusted thesis. Capital structure affects downside risk and valuation method selection. Corporate actions can make historical trends less comparable. Governance evidence can change how much confidence the analyst places in management’s disclosures, incentives, and capital-allocation choices.
| Area | What to examine | Series 86 interpretation |
|---|---|---|
| Debt mix | fixed versus floating, secured versus unsecured, maturity schedule | affects interest sensitivity and refinancing risk |
| Leverage | net debt, debt/EBITDA, debt-to-capital, debt-to-equity | must be interpreted relative to cash-flow stability and asset base |
| Coverage | interest coverage and operating cushion | weakening coverage can turn an equity story into a balance-sheet risk story |
| Liquidity | cash, revolver availability, near-term funding needs | tests whether the company can execute the plan without distressed financing |
| Preferred or convertibles | priority, dilution, conversion features | can change equity value and per-share outcomes |
Series 86 does not treat leverage as automatically bad. The question is whether the financing structure fits the business. Stable cash flows may support more debt than cyclical or unproven cash flows. Floating-rate debt may become more dangerous when rates rise. A company with near-term maturities and weaker earnings may need refinancing assumptions before a price target is credible.
Mergers, acquisitions, restructuring, divestitures, and consolidations can all change the analysis. An acquisition may add revenue and expected synergies, but it can also add leverage, integration risk, purchase-accounting effects, and a changed peer set. A restructuring charge may be one-time if it truly removes future costs, but repeated restructuring can be evidence that the business model is under pressure. A divestiture can improve focus while reducing scale or changing growth.
The exam often rewards the answer that adjusts the historical base instead of extrapolating pre-transaction trends mechanically. If a company sold a low-margin segment, prior consolidated margins may no longer describe the business. If a company made a large acquisition, prior organic growth and debt metrics may not be comparable.
Margins, ROE, ROA, ROIC, asset turnover, EPS, and dilution all appear more useful when interpreted through drivers. A higher ROE may reflect operating improvement, but it may also reflect leverage. A higher EPS figure may reflect buybacks rather than stronger operating income. A lower share count may benefit per-share metrics while reducing financial flexibility if cash was used aggressively.
The Series 86 answer should identify the driver behind the metric and decide whether it improves the investment case or merely changes presentation.
Proxy disclosures can reveal board structure, voting rights, ownership concentration, compensation design, related-party transactions, and potential conflicts. Governance matters because weak oversight or poorly aligned incentives can make management guidance less reliable. Strong governance does not guarantee good performance, but it can support confidence in capital allocation and disclosure quality.
When governance concerns appear in a fact pattern, the stronger answer usually treats them as part of research risk rather than as a legal footnote.
A company’s ROE improves sharply after a debt-financed acquisition, but operating margins are flat and interest coverage is weakening. Which Series 86 conclusion is strongest?
A. The higher ROE proves the company is fundamentally stronger B. The analyst should examine whether leverage, integration risk, and coverage weakness explain the return change C. Interest coverage is irrelevant because ROE is an equity metric D. The acquisition has no effect on comparability once consolidated statements are issued
Answer: B. Series 86 expects the analyst to interpret return measures in context. Leverage and corporate actions can change ratios without proving better operating performance.